Both semaglutide and tirzepatide bind to the glucagon-like-peptide 1 (GLP-1) hormone receptor found in the human gut.

This has many beneficial effects, but primary among them is extremely potent appetite suppression and dramatic slowing of emptying of the stomach—eliminating cravings and causing a rapid reduction in body weight.

Tirzepatide is a second generation medication which binds to an additional receptor called the glucose-dependent insulinotropic polypeptide (GIP) receptor. This dual-receptor action results in even more dramatic results.

Our formulations of both semaglutide and tirzepatide are compounded with pyridoxine (also known as vitamin B-6), which helps decrease unwanted gastrointestinal side effects such as nausea.